Dr. David Samadi Offers Outlook on Candidate Mitt Romney’s Prostate Treatment

Prostate Cancer is one of the deadliest diseases that can affect older men. Left undetected, Prostate Cancer can lead to death in many cases. Now, a renowned urologist offers his analysis on the prostate procedure undergone by Utah Senatorial candidate and former Presidential candidate Mitt Romney.

So how deadly is prostate cancer? For men over the age of 50, prostate cancer is one of the most deadly forms of cancer. In fact, there are over 1.4 million cases of prostate cancer each year resulting in over 300,000 annual deaths. That is why it is important for men over the age of 50 to be checked for early detection.

In the case of Mitt Romney, the prostate cancer was detected early and a surgical procedure could be performed. For candidate Romney, the procedure was performed at the University of California Hospital at Irvine by Dr. Thomas Ahlering. According to Dr. David Samadi, the procedure was a success and Mr. Romney will be healthy enough to go forward with his Senatorial campaign.

Because prostate cancer is common in older men, many well-known politicians have had prostate procedures performed leading to a full recovery. Some of the politicians who have had prostate procedures performed include former Secretary of State Colin Powell as well as former Presidential candidate John Kerry.

Dr. David Samadi is an ardent advocate of surgery over chemotherapy to treat prostate cancer. In Dr. Samadi’s own words, the survival rate for someone who has a surgical procedure to remove a localized cancerous prostate is 100%. Chemotherapy, on the other hand, can lead to a number of side effects that can harm and potentially kill the person who is being treated.

Additionally, Dr. Samadi states that if chemotherapy is performed and it turns out that cancer has spread, then the five-year survival rate for the patient drops to about 30%. Dr. Samadi also mentioned that chemotherapy could also expose patients to secondary cancer that could affect other organs of the body.

Dr. David Samadi works at Lenox Hill Hospital as the Chairman of Urology as well as the Chief of Robotic Surgery. Dr. Samadi was educated at Stony Brook University where he received a degree in Biochemistry. Afterward, he received his M.D. at Stony Brook School of Medicine. After completing his urology postdoctorate training at Montefiore Medical Center, Dr. Samadi completed his oncology fellowship at Memorial Sloan Kettering Cancer Center.

Dr. David Samadi Provides Update about Mitt Romney’s Cancer Prognosis

Dr. David Samadi, Chief Urologist and Chief of Robotic Surgery at Lenox Hill Hospital in New York details the positive prognosis about Mitt Romney’s prostate cancer diagnosis. Mitt Romney, 70, was diagnosed with prostate cancer after discovering a slow-growing tumor in 2017.

Dr. David Samadi has much insight to offer on the topic as he specializes in Urology and has been practicing medicine since graduating from Stony Brook School of Medicine in 1994. Dr. Samadi continued his post-graduate studies in urology at Montefiore Medical Center. He also completed studies in proctology and completed a fellowship in oncology proctology at Memorial Sloan Kettering Cancer Center in 2001.

Dr. Samadi went on to work at Columbia Presbyterian Hospital before joining the faculty at Mt. Sinai School of Medicine. He went on to become Mt. Sinai’s Vice Chair of the Department of Urology as well as the Chief of Robotics & Minimally Invasive Surgery. In 2013 Dr. David Samaid moved to Lenox Hill Hospital as Chair of Urology and Chief of Robotic Surgery.

Dr. Samadi has treated patients who have also been diagnosed with prostate cancer like Mitt Romney. While not all cases of prostate cancer are the same and some do require specialized treatment, Mitt Romney was diagnosed with the most common and most curable form of prostate cancer for a man his age. Over half of prostate cancer diagnosis’s occur in men 65 or older and is rare in men under 40.

Mitt Romney has had a positive prognosis update after choosing surgery versus radiation to tackle his cancer. Dr. Samadi recommends surgery first to treat prostate cancer, especially for cancer that is localized and hasn’t spread. The survival rates for men who choose surgery versus radiation is higher and men who choose surgery over radiation have lesser chance of the cancer returning.

Also as Dr. Samadi explains treating with radiation comes with more risk and makes surgery less effective when utilized as a second choice for treatment. Chances of secondary cancers, especially in the bladder and colon, are higher when radiation treatment is used. For men who have a tumor that hasn’t spread, treatment with surgery has almost a one hundred percent survival rate according to Dr. Samadi.

Mitt Romney joins a number of public figures that have undergone surgery for prostate cancer including former presidential candidate John Kerry. Dr. Samadi’s advice to any man diagnosed with prostate cancer is to find a qualified doctor to help determine the best treatment plan to ensure a positive outcome like Mitt Romney’s positive prognosis.